Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues.
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.
Recuro Health offers a holistic suite of virtual care services and supplemental benefits.
Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development.
Vizgen provides spatial multi-omics platforms enabling researchers to reveal cellular insights through spatial transcriptomics proteomics.
Designing innovative technologies focused on accelerating global access to biotherapeutics.
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.
SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Protillion Biosciences specializes in the design and development of protein-based drugs.
Generate Biomedicines is a biotech company that combines biology, machine learning, and biological engineering to create biomedicines.
EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Aledade is a primary care center.
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.
ARCH Venture Partners has invested in 236 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Pharmaceutical. The firm invests across 22 different industry categories.
Among tracked funding rounds, EQRx received $1.2B in a Post-IPO Equity round. ARCH Venture Partners's total known invested capital is $22.6B.
ARCH Venture Partners's average investment size is $122.9M across its portfolio of 236 companies.
Recent ARCH Venture Partners portfolio additions include Magnet Biomedicine, ROME Therapeutics, OncoResponse, Recuro Health, bit.bio. These companies were founded in 2020 or later.